OBGYN.net Conference CoverageFrom ISGE - Montreal, Canada - April, 1999
click here for RealAudio/Video version *requires RealPlayer- free download
"Hi, this is Mark Surrey from Los Angeles. We're speaking from the ISGE meeting in Montreal, Canada, in regard to some of the newer advances in operative endoscopy. This particular meeting, we're going to address some of the results that we've had from the procedure described as transvaginal hydrolaparoscopy, which is a minimally invasive process utilized to evaluate the adnexa in the infertility patient. This is a procedure performed by inserting a dilating Veress cannula through the cul-de-sac in the midline, flooding the peritoneum with saline, approximately 200-300 cc's, and evaluating through a 2.7 mm lens laparoscope the peritoneal findings. We're going to be addressing the complications of this procedure as such, as that we've reviewed our data and the data from two large European centers in Dusseldorf, Germany and in Leven, Belgium. What we've found is approximately a 1% incidence of rectal perforations, and essentially no incidence of ureteral or general urinary perforations, and no significant incidence of vascular perforations. The rectal perforations that have been reported have all been pre- or retroperitoneal, and therefore, have been managed conservatively with antibiotics - none of which have required any additional surgical procedure, and six-month follow-up on these patients have revealed no additional complications. In conclusion, we feel that so far the complications reported from this procedure are well within the range of those reported from traditional transabdominal laparoscopic approach, and therefore, this seems to be a process that we see a bright future for.
Thank you."
Pioglitazone outperforms metformin in IVF for PCOS-related infertility
May 6th 2024A recent double-blind, randomized clinical trial revealed a higher clinical pregnancy rate with pioglitazone compared to metformin in polycystic ovarian syndrome patients undergoing in vitro fertilization, suggesting potential for improved outcomes.
Read More
Reducing multifetal pregnancy through publicly funded IVF programs
April 26th 2024Learn how a mandatory elective single-embryo transfer policy in publicly funded in vitro fertilization programs significantly decreases multifetal pregnancy rates, offering insights into mitigating risks in assisted reproduction.
Read More
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More